HealthCare Global Enterprises Ltd

HealthCare Global Enterprises Ltd

$HCGHospitalNSEBSE

HealthCare Global Enterprises Ltd (HCG) last traded at ₹720, a market capitalisation of ₹10,750 crore, on a P/E of 223. Over the past 52 weeks the stock has ranged between ₹513 and ₹800. HealthCare Global Enterprises Ltd last reported results for the quarter ended Jun 2026, with sales of ₹695 crore and net profit of ₹16 crore. HealthCare Global Enterprises Ltd’s annual general meeting is scheduled for 18 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

HealthCare Global Enterprises Ltd share price and key metrics

Current price
₹720
Market cap
₹10,750 cr
Stock P/E
223
Book value
₹89.2
ROE
2.55%
ROCE
8.31%
Dividend yield
0.00%
52w high / low
800/513

Metrics as of 25 Aug 2026. Not real time.

HealthCare Global Enterprises Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹695 cr, up 13.4% from ₹613 cr a year earlier. Net profit was ₹16 cr, up 166.7% year on year.

HealthCare Global Enterprises Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales554559585613647633652695
Expenses451470480505524524527573
Operating profit10288106108123110125122
OPM %18%16%18%18%19%17%19%18%
Other income1161083-10-1813
Interest3641444544454340
Depreciation5057585863616370
Profit before tax28-3141220-6125
Tax %25%-335%50%50%-4%30%-223%34%
Net profit2187621-8416
EPS (₹)1.220.470.500.321.09-0.630.150.92

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

HealthCare Global Enterprises Ltd annual results

HealthCare Global Enterprises Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,0091,3951,6911,9082,2182,5452,627
Operating profit122234297327384466480
OPM %12%17%18%17%17%18%18%
Net profit-221391841492333
EPS (₹)-14.583.651.993.273.010.921.53

TTM is the trailing twelve months to the most recent quarter.

HealthCare Global Enterprises Ltd growth and returns

Compounded Sales Growth
10 Years
16%
5 Years
20%
3 Years
15%
TTM
14%
Compounded Profit Growth
10 Years
39%
5 Years
18%
3 Years
-1%
TTM
30%
Stock Price CAGR
10 Years
13%
5 Years
27%
3 Years
29%
1 Year
6%
Return on Equity
10 Years
-1%
5 Years
4%
3 Years
4%
Last Year
3%

HealthCare Global Enterprises Ltd shareholding pattern

Promoters held 64.21% at Jun 2026, up from 62.46% at Jun 2025. FIIs 2.73% and DIIs 19.20%.

HealthCare Global Enterprises Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters71.23%71.22%71.22%62.46%63.78%63.77%64.21%64.21%
FIIs4.30%2.77%2.44%2.16%3.59%3.22%2.76%2.73%
DIIs11.64%12.94%12.48%13.22%18.36%18.30%18.91%19.20%
Public12.84%13.07%13.86%22.17%14.28%14.71%14.15%13.86%
No. of shareholders29,67032,82045,39447,02846,97045,36647,64948,905

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is HealthCare Global Enterprises Ltd’s AGM?

HealthCare Global Enterprises Ltd’s annual general meeting is scheduled for 18 Sept 2026.

  • AGM28th Annual General Meeting to be held via Video Conferencing

See the full results calendar for every Indian company reporting in the next 30 days.

HealthCare Global Enterprises Ltd corporate filings

  • Newspaper advertisement pertaining to Notice of Annual General Meeting in accordance with MCA General Circular No. 20/2020 dated May 05, 2020.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Ltd has published a newspaper advertisement regarding the…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Earnings Call TranscriptCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited reported Q1 FY27 revenue of 695.1 crore, a 13%…

    Read the full analysis
  • Newspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, approved at the meeting of Board of Directors held ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited has released its unaudited financial results for…

    Read the full analysis
  • This is to inform that the Company will be participating in the group investor meeting hosted by Ambit Capital in Bangalore.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Ltd has announced its participation in a group investor…

    Read the full analysis
  • This is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on August 07, 2026, to discuss the Unaudited Financial Results (Standalone and Consolidated) ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited has formally notified the stock exchanges regarding…

    Read the full analysis
  • Press release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited reported a strong Q1 FY27 performance with revenue…

    Read the full analysis
  • Investor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited reported a strong Q1 FY2027 performance with…

    Read the full analysis
  • Monitoring Agency Report for the quarter ended June 30, 2026, in relation to the Rights Issue of the Company..Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited has released its Monitoring Agency Report for the…

    Read the full analysis
  • Statement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30, 2026.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited has filed a statement confirming no deviation in…

    Read the full analysis
  • The Board of Directors has approved the re-appointment of M/s Rao Murthy & Associates, Cost Accountants as Cost Auditors of the Company for the financial year 2026-27.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited has formally announced the re-appointment of M/s…

    Read the full analysis
  • The Board of Directors of the Company has approved a further investment of up to INR 16 Crores in HCG Rajkot Hospitals LLP, a wholly-owned subsidiary of the Company.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited has announced a further cash investment of up to…

    Read the full analysis
  • The Company has announced the Outcome of the Board meeting held on August 06, 2026, including approval of unaudited financial results of the Company for the quarter ended June 30, 2026.Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises reported consolidated revenue of 693.39 crore for the…

    Read the full analysis
  • Pursuant to Regulation 30 of LODR, we would like to inform that HCG Manavata Oncology LLP, a subsidiary LLP, of the Company has entered into agreement to acquire 26% equity stake in Epic ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: HealthCare Global Enterprises Limited (HCG) has announced that its subsidiary, HCG…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track HealthCare Global Enterprises Ltd

Cruxal reads every HealthCare Global Enterprises Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

HealthCare Global Enterprises Ltd (HCG) Results, Financials & Share Price | Cruxal